Gene Transfer via Intranasal Delivery of Adenoviral Vectors
Author Information
Author(s): Damjanovic Daniela, Zhang Xizhong, Mu Jingyu, Fe Medina Maria, Xing Zhou
Primary Institution: McMaster University
Hypothesis
Does intranasal delivery of recombinant adenoviral vectors lead to significant gene transfer in the respiratory system without affecting the brain?
Conclusion
Intranasal delivery of replication-defective adenoviral vectors results in gene transfer primarily in the respiratory system and only a moderate level in the olfactory bulb, with little to no dissemination to the brain.
Supporting Evidence
- Intranasal delivery led to significant gene transfer in the lung.
- Moderate gene transfer was observed in the olfactory bulb.
- No significant gene transfer was detected in the brain.
- Fluorescence imaging showed patchy expression in the trachea.
- Luciferase activity peaked in the lung at days 3 and 7.
- Low levels of inflammation were observed in the lung and liver.
- PCR confirmed the presence of adenoviral sequences in the lung and olfactory bulb.
Takeaway
When you spray a special virus up your nose, it mostly helps your lungs and a little bit goes to your nose's brain area, but it doesn't really get into the big brain part.
Methodology
The study used fluorescence imaging, luciferase quantification, and PCR to assess transgene distribution in various organs after intranasal delivery of adenoviral vectors.
Potential Biases
Potential bias in the interpretation of fluorescence imaging results.
Limitations
The study primarily focused on a single animal model and may not fully represent human responses.
Participant Demographics
Female BALB/c mice aged 6 to 10 weeks.
Statistical Information
P-Value
p ≤ 0.01
Statistical Significance
p ≤ 0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website